Compare ALOT & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALOT | MDWD |
|---|---|---|
| Founded | 1969 | 2000 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.5M | 181.1M |
| IPO Year | 1995 | 2013 |
| Metric | ALOT | MDWD |
|---|---|---|
| Price | $28.72 | $14.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | ★ 289.2K | 80.3K |
| Earning Date | 04-13-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.94 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $150,515,000.00 | N/A |
| Revenue This Year | N/A | $48.92 |
| Revenue Next Year | N/A | $35.04 |
| P/E Ratio | $358.13 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.96 | $13.54 |
| 52 Week High | $28.68 | $21.11 |
| Indicator | ALOT | MDWD |
|---|---|---|
| Relative Strength Index (RSI) | 90.37 | 44.61 |
| Support Level | $14.35 | $13.65 |
| Resistance Level | N/A | $15.18 |
| Average True Range (ATR) | 0.07 | 0.47 |
| MACD | -0.49 | 0.01 |
| Stochastic Oscillator | 100.00 | 24.19 |
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Aerospace. It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.